Neuromyelitis Optica Spectrum Disorder in a 29-Year-Old Woman on Semaglutide: A Case of Acute Myelopathy Following Weight Loss Treatment. (P3-2.003)
This case report aims to investigate the potential link between the glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide for weight loss and the development of seronegative neuromyelitis optica spectrum disorder (NMOSD), broadening our understanding of possible NMOSD triggers.
Authors
- Ahmad Almutlaq (ORCID: https://orcid.org/0000-0002-0209-9919)
- Rana AlDosary
- Osama J. Aldraihem
- Moneera Aldraihem (ORCID: https://orcid.org/0000-0001-7252-3204)
- Ghadah Shareefi
- Walaa Alyami
Institutions
- King Fahd Medical City (SA)
- King Saud University (SA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210555
- Primary Topic
- Parkinson's Disease and Spinal Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00